Contents | 7 of 33

First Cases of Dominant Optic Atrophy in Saudi Arabia: Report of Two Novel OPA1 Mutations

Update Item Information
Title Journal of Neuro-Ophthalmology, December 2013, Volume 33, Issue 4
Date 2013-12
Language eng
Format application/pdf
Type Text
Publication Type Journal Article
Collection Neuro-Ophthalmology Virtual Education Library: Journal of Neuro-Ophthalmology Archives: https://novel.utah.edu/jno/
Publisher Lippincott, Williams & Wilkins
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management © North American Neuro-Ophthalmology Society
ARK ark:/87278/s6c282jn
Setname ehsl_novel_jno
ID 227537
Reference URL https://collections.lib.utah.edu/ark:/87278/s6c282jn

Page Metadata

Title First Cases of Dominant Optic Atrophy in Saudi Arabia: Report of Two Novel OPA1 Mutations
Creator Galvez-Ruiz, Alberto; Neuhaus, Christine; Bergmann, Carsten; Bolz, Hanno
Affiliation Neuro-Ophthalmology Division (AG-R), King Khaled Eye Specialist Hospital, Riyadh, Kingdom of Saudi Arabia; Center for Human Genetics (CN, CB, HB), Bioscientia, Ingelheim Germany; Center for Clinical Research (CB), University Hospital of Freiburg, Freiburg, Germany; and Institute of Human Genetics (HB), University Hospital of Cologne, Cologne, Germany
Abstract Fifty to 60% of patients with dominant optic atrophy (DOA) have mutations of the OPA1 gene, which encodes dynamin-related GTPase, a protein of the internal mitochondrial membrane. To date, more than 200 OPA1 mutations in the OPA1 gene have been described. However, DOA is genetically heterogeneous with certain families linked to other chromosomal loci, that is, OPA3, OPA4, OPA5, and OPA7. This study describes a clinical series of 40 patients from Saudi Arabia with a positive DOA phenotype (i.e., decreased visual acuity during the first 2 decades of life, temporal or global optic disc pallor, and absence of other neurological or ophthalmological diseases that could explain the optic neuropathy) who underwent molecular genetic testing for OPA1 (and, in some cases, for OPA3). This study describes for the first time 4 OPA1 mutations in DOA patients from Saudi Arabia, including 2 novel OPA1 mutations in 2 different patients. The question remains whether certain patients in Saudi Arabia with a clearly defined DOA ph otype may be due to mutations in chromosomal loci other than OPA1 and OPA3. It is likely that genetic alterations associated with different loci will be discovered in the future.
Subject Adolescent; Adult; Child; Female; GTP Phosphohydrolases; Genetic Association Studies; Humans; Male; Middle Older people; Mutation; Optic Atrophy, Autosomal Dominant; Proteins; Retrospective Studies; Saudi Arabia; Young Adult
OCR Text Show
Format application/pdf
Publication Type Journal Article
Collection Neuro-Ophthalmology Virtual Education Library: Journal of Neuro-Ophthalmology Archives: https://novel.utah.edu/jno/
Publisher Lippincott, Williams & Wilkins
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management © North American Neuro-Ophthalmology Society
Setname ehsl_novel_jno
ID 227510
Reference URL https://collections.lib.utah.edu/ark:/87278/s6c282jn/227510
Back to Search Results